Bairkdar Majd, Patasova Karina, Andell Pontus, Holmqvist Marie
Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Rheumatol Adv Pract. 2025 May 9;9(2):rkaf054. doi: 10.1093/rap/rkaf054. eCollection 2025.
To study the risk of acute myocardial infarction (AMI) in patients with SSc in a population-based cohort.
Using nationwide Swedish registers, we identified patients with incident SSc 2004-19 and age- and sex-matched comparators from the general population (1:10). Our primary outcome was incident AMI or death from incident AMI. We started follow-up from SSc diagnosis until the primary outcome, death from other cause than AMI, emigration or study end (31 December 2019). We estimated crude AMI incidence rate. We used flexible parametric models to explore the relative risk of AMI over time since diagnosis. We also used age as time scale to explore how AMI risk changes over increasing age. We also studied the outcomes of AMI in SSc compared with the matched comparators.
We identified 1579 patients and 16 064 comparators. The incidence rate of AMI was 75.2 (95% CI 58.8-94.6) per 10 000 person-years in patients with SSc and 37.5 (95% CI 34.0-41.3) in the comparators, median follow-up was 5.2 and 6.3 years, respectively. The adjusted hazard ratio (HR) was highest during the first year after SSc diagnosis (HR 3.1, 95% CI 2.0-4.6). In patients with SSc, the risk of AMI increased more rapidly with increasing age compared with the comparators. AMI in SSc was associated with higher risk of mortality (HR 2.7, 95% CI 1.6-4.4) but not 30-day readmission (HR 1.3, 95% CI 0.7-2.0) compared with the comparators.
In line with previous studies, SSc is associated with a 2-fold increase in AMI incidence compared with the general population.
在一项基于人群的队列研究中,研究系统性硬化症(SSc)患者发生急性心肌梗死(AMI)的风险。
利用瑞典全国性登记系统,我们确定了2004年至2019年期间新发SSc患者以及来自普通人群的年龄和性别匹配的对照者(1:10)。我们的主要结局是新发AMI或因新发AMI死亡。我们从SSc诊断开始随访,直至出现主要结局、因AMI以外的其他原因死亡、移民或研究结束(2019年12月31日)。我们估计了粗AMI发病率。我们使用灵活的参数模型来探讨自诊断以来AMI的相对风险随时间的变化。我们还使用年龄作为时间尺度来探讨AMI风险如何随年龄增长而变化。我们还比较了SSc患者与匹配对照者的AMI结局。
我们确定了1579例患者和16064例对照者。SSc患者的AMI发病率为每10000人年75.2例(95%CI 58.8 - 94.6),对照者为37.5例(95%CI 34.0 - 41.3),中位随访时间分别为5.2年和6.3年。校正后的风险比(HR)在SSc诊断后的第一年最高(HR 3.1,95%CI 2.0 - 4.6)。与对照者相比,SSc患者中,AMI风险随年龄增长上升得更快。与对照者相比,SSc患者发生AMI后死亡风险更高(HR 2.7,95%CI 1.6 - 4.4),但30天再入院风险无差异(HR 1.3,95%CI 0.7 - 2.0)。
与先前研究一致,与普通人群相比,SSc患者的AMI发病率增加了两倍。